Genera Biosystems receives TGA approval for its PapType HPV detection and genotyping test
Genera Biosystems announced that the Australian Therapeutic Goods Administration (TGA) has approved the entry of the company’s PapType Human Papillomavirus (HPV) test kit onto the Australian Register of Therapeutic Goods (ARTG). The company is now permitted to supply PapType to Australian customers, subject to the terms of the licence.
“This is a very significant, and tremendously satisfying achievement for everyone associated with our company” commented chairman, Mr. Fernando Careri. “To have taken a technological concept, and turned it into a product which will contribute to the health and well being of Australian women is something of which we should be extremely proud. Genera is already engaged in broad commercial discussions, and will now also engage in discussions with women’s health specialists around the country to investigate how PapType might be incorporated into national cervical cancer screening guidelines”.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Minimise errors in pharmaceutical processes and reduce risks - Tyrolean start-up Innerspace secures € 5.7 Million for Further Expansion to the USA

Viruses on the run - ETH Zurich Professor Ari Helenius awarded Benoist Prize
Taxus_baccata
Horizon Discovery and Domainex Ltd Collaborate to Support Lead Optimization Oncology Program - Horizon’s isogenic cell lines accurately modeling tumor mutations to be used to profile lead compounds
Philopteridae
List_of_Orchidaceae_genera
